Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Allogene Therapeutics Inc., 3 years.
Allogene Therapeutics Inc.
Director
Ginkgo Bioworks Holdings Inc.
Director
UroGen Pharma Ltd.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 24, 2025 | Allogene Therapeutics Inc. | Grant or award | +369,957 | — | — |
| Jun 12, 2024 | Ginkgo Bioworks Holdings Inc. | Option exercise | +105,263 | — | — |
| May 16, 2024 | Allogene Therapeutics Inc. | Grant or award | +344,828 | $2.90 | $1,000,001 |
| May 16, 2024 | Allogene Therapeutics Inc. | Open-market purchase | +1,724,137 | $2.90 | $4,999,997 |
| Jan 25, 2024 | Allogene Therapeutics Inc. | Grant or award | +211,973 | — | — |
| Mar 22, 2023 | Allogene Therapeutics Inc. | Grant or award | +1,282,976 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.